Nephrotoxicity Associated with Intravenous Colistin (Colistimethate Sodium) Treatment at a Tertiary Care Medical Center

被引：291

作者：

Hartzell, Joshua D. ^{[1
]}

Neff, Robert ^{[2
]}

Ake, Julie ^{[1
]}

Howard, Robin ^{[3
]}

Olson, Stephen ^{[2
]}

Paolino, Kristopher ^{[1
]}

Vishnepolsky, Mark ^{[2
]}

Weintrob, Amy ^{[1
]}

Wortmann, Glenn ^{[1
]}

机构：

[1] USA, Infect Dis Serv, Walter Reed Army Med Ctr, Washington, DC 20307 USA

[2] Walter Reed Army Med Ctr, Dept Med, Serv Nephrol, Washington, DC 20307 USA

[3] Walter Reed Army Med Ctr, Dept Clin Invest, Washington, DC 20307 USA

来源：

CLINICAL INFECTIOUS DISEASES | 2009年 / 48卷 / 12期

关键词：

RESISTANT PSEUDOMONAS-AERUGINOSA; VENTILATOR-ASSOCIATED PNEUMONIA; NEGATIVE BACTERIAL-INFECTIONS; ACINETOBACTER-BAUMANNII; THERAPY; POLYMYXINS; DEFINITION; TOXICITY; EFFICACY; SAFETY;

D O I：

10.1086/599225

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The incidence of acute renal failure, defined by the risk, injury, or failure criteria of the RIFLE criteria ( risk, injury, failure, loss, and end-stage kidney disease), in 66 patients who received colistimethate sodium was 45%, and 21% of patients stopped therapy because of nephrotoxicity. The RIFLE criteria should be used in the future to allow for comparison of nephrotoxicity among studies.

引用

页码：1724 / 1728

页数：5

共 20 条

[1]

BAINES RD, 1964, JAMA-J AM MED ASSOC, V190, P278

[2] Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group [J].

Bellomo, R ;

Ronco, C ;

Kellum, JA ;

Mehta, RL ;

Palevsky, P .

CRITICAL CARE, 2004, 8 (04) :R204-R212

[3] Modulation of polymyxin B effects on mammalian urinary bladder [J].

Berg, JR ;

Spilker, CM ;

Lewis, SA .

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1998, 275 (02) :F204-F215

[4] Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria [J].

Falagas, M. E. ;

Kasiakou, S. K. ;

Kofteridis, D. P. ;

Roditakis, G. ;

Samonis, G. .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2006, 25 (09) :596-599

[5] The Use of Intravenous and Aerosolized Polymyxins for the Treatment of Infections in Critically III Patients: A Review of the Recent Literature [J].

Falagas, Matthew E. ;

Kasiakou, Sofia K. ;

Tsiodras, Sotirios ;

Michalopoulos, Argyris .

CLINICAL MEDICINE & RESEARCH, 2006, 4 (02) :138-146

[6] Toxicity of polymyxins: a systematic review of the evidence from old and recent studies [J].

Falagas, Matthew E. ;

Kasiakou, Sofia K. .

CRITICAL CARE, 2006, 10 (01)

[7] Nephrotoxicity of intravenous colistin: a prospective evaluation [J].

Falagas, ME ;

Fragoulis, KN ;

Kasiakou, SK ;

Sermaidis, GJ ;

Michalopoulos, A .

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 26 (06) :504-507

[8] Toxicity after prolonged (more than four weeks) administration of intravenous colistin [J].

Falagas, ME ;

Rizos, M ;

Bliziotis, IA ;

Rellos, K ;

Kasiakou, SK ;

Michalopoulos, A .

BMC INFECTIOUS DISEASES, 2005, 5 (1)

[9] Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections [J].

Falagas, ME ;

Kasiakou, SK .

CLINICAL INFECTIOUS DISEASES, 2005, 40 (09) :1333-1341

[10] Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: a matched case-control study [J].

Kallel, H. ;

Hergafi, L. ;

Bahloul, M. ;

Hakim, A. ;

Dammak, H. ;

Chelly, H. ;

Ben Hamida, C. ;

Chaari, A. ;

Rekik, N. ;

Bouaziz, M. .

INTENSIVE CARE MEDICINE, 2007, 33 (07) :1162-1167

← 1 2 →